Trial Profile
Genotype Stratified Pharmacokinetic Study of Montelukast
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Asthma
- Focus Pharmacogenomic; Pharmacokinetics
- Acronyms GSPOM
- 21 Jan 2020 Status changed from recruiting to completed.
- 23 Jan 2014 Planned End Date changed from 1 Feb 2013 to 1 Sep 2014, according to ClinicalTrials.gov record.
- 03 Nov 2011 Planned End Date changed from 1 Dec 2010 to 1 Feb 2013 as reported by ClinicalTrials.gov.